{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:58:28Z","timestamp":1791251908141,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03176-w","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T15:01:52Z","timestamp":1718982112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Syringocystadenocarcinoma papilliferum: a systematic review of clinical characteristics, reappraisal of associations, diagnostic pitfalls and management challenges"],"prefix":"10.1007","volume":"316","author":[{"given":"Leo","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1622-1097","authenticated-orcid":false,"given":"Amor","family":"Khachemoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,21]]},"reference":[{"key":"3176_CR1","doi-asserted-by":"publisher","unstructured":"Abrari A, Mukherjee U (2011) Syringocystadenocarcinoma papilliferum at unusual site: inherent lesional histologic polymorphism is the pathognomon. BMJ Case Rep 2011. https:\/\/doi.org\/10.1136\/bcr.05.2011.4254","DOI":"10.1136\/bcr.05.2011.4254"},{"key":"3176_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ad.2017.03.021","volume":"109","author":"AD Agull\u00f3 P\u00e9rez","year":"2018","unstructured":"Agull\u00f3 P\u00e9rez AD, Bonaut Iriarte B, C\u00f3rdoba Iturriagagoitia A, Valcayo Pe\u00f1alba A (2018) Syringocystadenocarcinoma Papilliferum: Case Report and Review of the literature. Actas Dermosifiliogr 109:366\u2013369. https:\/\/doi.org\/10.1016\/j.ad.2017.03.021","journal-title":"Actas Dermosifiliogr"},{"key":"3176_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.adengl.2017.03.043","volume":"109","author":"AD Agull\u00f3 P\u00e9rez","year":"2018","unstructured":"Agull\u00f3 P\u00e9rez AD, Bonaut Iriarte B, C\u00f3rdoba Iturriagagoitia A, Valcayo Pe\u00f1alba A (2018) Syringocystadenocarcinoma Papilliferum: Case Report and Review of the literature. Actas Dermosifiliogr 109:366\u2013369. https:\/\/doi.org\/10.1016\/j.adengl.2017.03.043","journal-title":"Actas Dermosifiliogr"},{"key":"3176_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/cup.13534","volume":"46","author":"V Alegr\u00eda-Landa","year":"2019","unstructured":"Alegr\u00eda-Landa V, Kutzner H, Requena L (2019) Syringocystadenocarcinoma papilliferum associated with atypical stroma: a hitherto undocumented variant of sarcomatoid carcinoma. J Cutan Pathol 46:867\u2013871. https:\/\/doi.org\/10.1111\/cup.13534","journal-title":"J Cutan Pathol"},{"key":"3176_CR5","doi-asserted-by":"publisher","first-page":"9056209","DOI":"10.1155\/2020\/9056209","volume":"2020","author":"E Altunel","year":"2020","unstructured":"Altunel E, Perepletchikov A, Kozyreva O (2020) Metastatic syringocystadenocarcinoma papilliferum: a Case Report, Tumor genomic profiling, and Literature Review. Case Rep Oncol Med 2020:9056209. https:\/\/doi.org\/10.1155\/2020\/9056209","journal-title":"Case Rep Oncol Med"},{"key":"3176_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1346-8138.2003.tb00363.x","volume":"30","author":"Y Arai","year":"2003","unstructured":"Arai Y, Kusakabe H, Kiyokane K (2003) A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum. J Dermatol 30:146\u2013150. https:\/\/doi.org\/10.1111\/j.1346-8138.2003.tb00363.x","journal-title":"J Dermatol"},{"key":"3176_CR7","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1097\/SCS.0b013e31826cffc6","volume":"24","author":"H Arslan","year":"2013","unstructured":"Arslan H, Diyarbakrl M, Batur S, Demirkesen C (2013) Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis. J Craniofac Surg 24:e38\u201340. https:\/\/doi.org\/10.1097\/SCS.0b013e31826cffc6","journal-title":"J Craniofac Surg"},{"key":"3176_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1524-4725.2011.01872.x","volume":"37","author":"OE Aydin","year":"2011","unstructured":"Aydin OE, Sahin B, Ozkan HS, Gore O (2011) A rare tumor: syringocystadenocarcinoma papilliferum. Dermatol Surg off Publ Am Soc Dermatol Surg Al 37:271\u2013274. https:\/\/doi.org\/10.1111\/j.1524-4725.2011.01872.x","journal-title":"Dermatol Surg off Publ Am Soc Dermatol Surg Al"},{"key":"3176_CR9","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.4081\/cp.2012.e71","volume":"2","author":"GD Bakhshi","year":"2012","unstructured":"Bakhshi GD, Wankhede KR, Tayade MB, Shenoy SS, Gore ST, Valand AG (2012) Carcino-sarcoma in a case of syringocystadenoma papilliferum: a rare entity. Clin Pract 2:e71. https:\/\/doi.org\/10.4081\/cp.2012.e71","journal-title":"Clin Pract"},{"key":"3176_CR10","doi-asserted-by":"publisher","first-page":"e39424","DOI":"10.7759\/cureus.39424","volume":"15","author":"A Bashinskaya","year":"2023","unstructured":"Bashinskaya A, Shapiro L, Thompson C, Truett AP, Moody P (2023) A case of Syringocystadenocarcinoma Papilliferum: not your usual suspect. Cureus 15:e39424. https:\/\/doi.org\/10.7759\/cureus.39424","journal-title":"Cureus"},{"key":"3176_CR11","doi-asserted-by":"crossref","unstructured":"Basu P, Erickson CP, Calame A, Cohen PR (2020) Nevus sebaceus with syringocystadenoma papilliferum, prurigo nodularis, apocrine cystadenoma, basaloid follicular proliferation, and sebaceoma: case report and review of nevus sebaceus-associated conditions. Dermatol Online J 26:13030\/qt85k968bk","DOI":"10.5070\/D3262047411"},{"key":"3176_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-2559.1996.t01-4-297345.x","volume":"28","author":"R Bondi","year":"1996","unstructured":"Bondi R, Urso C (1996) Syringocystadenocarcinoma papilliferum. Histopathology 28:475\u2013477. https:\/\/doi.org\/10.1046\/j.1365-2559.1996.t01-4-297345.x","journal-title":"Histopathology"},{"key":"3176_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.0303-6987.2005.320ag.x","volume":"32","author":"J Cai","year":"2005","unstructured":"Cai J, Patel P, Rasberry R, Slominski A, Balazs L (2005) Syringocystadenocarcinoma Papilliferum in situ: a Case Report and Review of the literature. J Cutan Pathol 32:78\u201379. https:\/\/doi.org\/10.1111\/j.0303-6987.2005.320ag.x","journal-title":"J Cutan Pathol"},{"key":"3176_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/DAD.0b013e3182a38bb9","volume":"36","author":"L Castillo","year":"2014","unstructured":"Castillo L, Moreno A, Tard\u00edo JC (2014) Syringocystadenocarcinoma papilliferum in situ: report of a case with late recurrence. Am J Dermatopathol 36:348\u2013352. https:\/\/doi.org\/10.1097\/DAD.0b013e3182a38bb9","journal-title":"Am J Dermatopathol"},{"key":"3176_CR15","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/DAD.0000000000000687","volume":"38","author":"J Chen","year":"2016","unstructured":"Chen J, Beg M, Chen S (2016) Syringocystadenocarcinoma Papilliferum in situ, a variant of cutaneous adenocarcinoma in situ: a Case Report with Literature Review. Am J Dermatopathol 38:762\u2013765. https:\/\/doi.org\/10.1097\/DAD.0000000000000687","journal-title":"Am J Dermatopathol"},{"key":"3176_CR16","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1524-4725.2004.30023.x","volume":"30","author":"C-C Chi","year":"2004","unstructured":"Chi C-C, Tsai R-Y, Wang S-H (2004) Syringocystadenocarcinoma papilliferum: successfully treated with Mohs micrographic surgery. Dermatol Surg off Publ Am Soc Dermatol Surg Al 30:468\u2013471. https:\/\/doi.org\/10.1111\/j.1524-4725.2004.30023.x","journal-title":"Dermatol Surg off Publ Am Soc Dermatol Surg Al"},{"key":"3176_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5858\/arpa.2022-0474-OA","volume":"148","author":"KM Cornejo","year":"2024","unstructured":"Cornejo KM, Hutchinson L, O\u2019Donnell P, Meng X, Tomaszewicz K, Shalin SC, Cassarino DS, Chan MP, Quinn TR, Googe PB, Nazarian RM (2024) Molecular profiling of Syringocystadenocarcinoma Papilliferum reveals RAS-Activating mutations. Arch Pathol Lab Med 148:215\u2013222. https:\/\/doi.org\/10.5858\/arpa.2022-0474-OA","journal-title":"Arch Pathol Lab Med"},{"key":"3176_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0190-9622(00)90136-1","volume":"42","author":"B Cribier","year":"2000","unstructured":"Cribier B, Scrivener Y, Grosshans E (2000) Tumors arising in nevus sebaceus: a study of 596 cases. J Am Acad Dermatol 42:263\u2013268. https:\/\/doi.org\/10.1016\/S0190-9622(00)90136-1","journal-title":"J Am Acad Dermatol"},{"key":"3176_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2559.1980.tb02939.x","volume":"4","author":"RVP DISSANAYAKE","year":"1980","unstructured":"DISSANAYAKE RVP, SALM R (1980) Sweat-gland carcinomas: prognosis related to histological type. Histopathology 4:445\u2013466. https:\/\/doi.org\/10.1111\/j.1365-2559.1980.tb02939.x","journal-title":"Histopathology"},{"key":"3176_CR20","doi-asserted-by":"publisher","first-page":"e1420","DOI":"10.1111\/jdv.19346","volume":"37","author":"A Dupont","year":"2023","unstructured":"Dupont A, Vergara R, Pacaud A, Dequidt L, Dutriaux C, Saunier V, Caumont C, Jullie M-L, Ta\u00efeb A, Morice-Picard F, Dousset L (2023) Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature. J Eur Acad Dermatol Venereol JEADV 37:e1420\u2013e1422. https:\/\/doi.org\/10.1111\/jdv.19346","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"3176_CR21","doi-asserted-by":"publisher","first-page":"8076649","DOI":"10.1155\/2022\/8076649","volume":"2022","author":"JN Halsey","year":"2022","unstructured":"Halsey JN, Faith EF, Logan SJ, Shenoy A, Schieffer KM, Cottrell CE, Lillis AP, Aldrink JH, Setty BA, Pearson GD (2022) Syringocystadenocarcinoma Papilliferum in a fifteen-year-old girl: a Case Report and Review of the literature. Case Rep Dermatol Med 2022:8076649. https:\/\/doi.org\/10.1155\/2022\/8076649","journal-title":"Case Rep Dermatol Med"},{"key":"3176_CR22","unstructured":"Hidradenoma https:\/\/www.pathologyoutlines.com\/topic\/skintumornonmelanocyticeccrineacrospiroma.html. Accessed 27 Apr 2024"},{"key":"3176_CR23","unstructured":"Hidradenoma papilliferum https:\/\/www.pathologyoutlines.com\/topic\/skintumornonmelanocytichidradenomapap.html. Accessed 27 Apr 2024"},{"key":"3176_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1600-0560.2009.01419.x","volume":"38","author":"R Hoekzema","year":"2011","unstructured":"Hoekzema R, Leenarts MFE, Nijhuis EWP (2011) Syringocystadenocarcinoma papilliferum in a linear nevus verrucosus. J Cutan Pathol 38:246\u2013250. https:\/\/doi.org\/10.1111\/j.1600-0560.2009.01419.x","journal-title":"J Cutan Pathol"},{"key":"3176_CR25","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1097\/IOP.0b013e318216366a","volume":"28","author":"AS Hoguet","year":"2012","unstructured":"Hoguet AS, Dolphin K, McCormick SA, Milman T (2012) Syringocystadenocarcinoma papilliferum of the eyelid. Ophthal Plast Reconstr Surg 28:e27\u201329. https:\/\/doi.org\/10.1097\/IOP.0b013e318216366a","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"3176_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/1346-8138.13070","volume":"43","author":"M-C Hsu","year":"2016","unstructured":"Hsu M-C, Liau J-Y, Hong J-L, Cheng Y, Liao Y-H, Chen J-S, Sheen Y-S, Hong J-B (2016) Secondary neoplasms arising from nevus sebaceus: a retrospective study of 450 cases in Taiwan. J Dermatol 43:175\u2013180. https:\/\/doi.org\/10.1111\/1346-8138.13070","journal-title":"J Dermatol"},{"key":"3176_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000381940","volume":"7","author":"N Iga","year":"2015","unstructured":"Iga N, Fujii H, Miyake T, Ehara M, Kore-Eda S (2015) Syringocystadenocarcinoma Papilliferum in the Perianal Area. Case Rep Dermatol 7:84\u201389. https:\/\/doi.org\/10.1159\/000381940","journal-title":"Case Rep Dermatol"},{"key":"3176_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1067\/mjd.2001.117723","volume":"45","author":"A Ishida-Yamamoto","year":"2001","unstructured":"Ishida-Yamamoto A, Sato K, Wada T, Takahashi H, Iizuka H (2001) Syringocystadenocarcinoma papilliferum: case report and immunohistochemical comparison with its benign counterpart. J Am Acad Dermatol 45:755\u2013759. https:\/\/doi.org\/10.1067\/mjd.2001.117723","journal-title":"J Am Acad Dermatol"},{"key":"3176_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/DAD.0b013e3181b96c0c","volume":"32","author":"DV Kazakov","year":"2010","unstructured":"Kazakov DV, Requena L, Kutzner H, Fernandez-Figueras MT, Kacerovska D, Mentzel T, Schwabbauer P, Michal M (2010) Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature. Am J Dermatopathol 32:340\u2013347. https:\/\/doi.org\/10.1097\/DAD.0b013e3181b96c0c","journal-title":"Am J Dermatopathol"},{"key":"3176_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/DAD.0000000000002049","volume":"43","author":"H Kneitz","year":"2021","unstructured":"Kneitz H, Goebeler M, R\u00fctten A (2021) Nevus Sebaceous of the Scalp with Stepwise Progression into Invasive Syringocystadenocarcinoma Papilliferum. Am J Dermatopathol 43:965\u2013969. https:\/\/doi.org\/10.1097\/DAD.0000000000002049","journal-title":"Am J Dermatopathol"},{"key":"3176_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1600-0463.2008.00027.x","volume":"117","author":"C Langner","year":"2009","unstructured":"Langner C, Ott A (2009) Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin. APMIS Acta Pathol Microbiol Immunol Scand 117:148\u2013150. https:\/\/doi.org\/10.1111\/j.1600-0463.2008.00027.x","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"3176_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5021\/ad.2019.31.5.559","volume":"31","author":"KG Lee","year":"2019","unstructured":"Lee KG, Choi W, Lim JS, Hahn HJ, Myung KB, Cheong SH (2019) Syringocystadenocarcinoma Papilliferum: a Case Report and Review of the literature. Ann Dermatol 31:559\u2013562. https:\/\/doi.org\/10.5021\/ad.2019.31.5.559","journal-title":"Ann Dermatol"},{"key":"3176_CR33","doi-asserted-by":"publisher","first-page":"e23521","DOI":"10.1016\/j.heliyon.2023.e23521","volume":"10","author":"JH Lee","year":"2024","unstructured":"Lee JH, Lee JD, Paulson K, Voillet V, Berndt A, Church C, Lachance K, Park SY, Yamamoto NK, Cromwell EA, Gottardo R, Chapuis AG, Nghiem P (2024) Enhancing immunogenic responses through CDK4\/6 and HIF2\u03b1 inhibition in Merkel cell carcinoma. Heliyon 10:e23521. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23521","journal-title":"Heliyon"},{"key":"3176_CR34","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.5858\/2009-0399-CR.1","volume":"134","author":"N Leeborg","year":"2010","unstructured":"Leeborg N, Thompson M, Rossmiller S, Gross N, White C, Gatter K (2010) Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literature. Arch Pathol Lab Med 134:1205\u20131209. https:\/\/doi.org\/10.5858\/2009-0399-CR.1","journal-title":"Arch Pathol Lab Med"},{"key":"3176_CR35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/cup.14080","volume":"48","author":"JD McBride","year":"2021","unstructured":"McBride JD, Billings SD, Komforti MK (2021) A rare case of syringocystadenocarcinoma papilliferum of the breast: an institutional retrospective case review and brief literature review. J Cutan Pathol 48:1387\u20131391. https:\/\/doi.org\/10.1111\/cup.14080","journal-title":"J Cutan Pathol"},{"key":"3176_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/ijd.12438","volume":"53","author":"SK Mohanty","year":"2014","unstructured":"Mohanty SK, Pradhan D, Diwaker P, Gami A, Hanna IT, Freedman AM, Turi GK (2014) Long-standing exophytic mass in the right infratemporal region. Syringocystadenocarcinoma papilliferum. Int J Dermatol 53:539\u2013542. https:\/\/doi.org\/10.1111\/ijd.12438","journal-title":"Int J Dermatol"},{"key":"3176_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.clinimag.2021.01.024","volume":"75","author":"JA Moore","year":"2021","unstructured":"Moore JA, Cui S, Berger N, Kim S, O\u2019Guinn D, Labow D, Kamath A (2021) Hidradenocarcinoma: a rare but challenging diagnosis. Clin Imaging 75:138\u2013142. https:\/\/doi.org\/10.1016\/j.clinimag.2021.01.024","journal-title":"Clin Imaging"},{"key":"3176_CR38","doi-asserted-by":"publisher","first-page":"574","DOI":"10.4103\/ijdvl.IJDVL_755_16","volume":"83","author":"RK Muthusamy","year":"2017","unstructured":"Muthusamy RK, Mehta SS (2017) Syringocystadenocarcinoma papilliferum with coexisting trichoblastoma: a case report with review of literature. Indian J Dermatol Venereol Leprol 83:574\u2013576. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_755_16","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3176_CR39","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s13193-023-01808-7","volume":"14","author":"S Naskar","year":"2023","unstructured":"Naskar S, Manohar A, H G S VD, Kumar RV, Srinath BS (2023) Syringocystadenocarcinoma Papilliferum of Thigh-a rare cutaneous malignancy with unusual histology and clinical presentation. Indian J Surg Oncol 14:900\u2013903. https:\/\/doi.org\/10.1007\/s13193-023-01808-7","journal-title":"Indian J Surg Oncol"},{"key":"3176_CR40","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.abd.2021.11.001","volume":"97","author":"MPdaS Neto","year":"2022","unstructured":"Neto MPdaS, de Assis BR, Andrade GR (2022) Sebaceous nevus of Jadassohn: review and clinical-surgical approach. Bras Dermatol 97:628\u2013636. https:\/\/doi.org\/10.1016\/j.abd.2021.11.001","journal-title":"Bras Dermatol"},{"key":"3176_CR41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000489255","volume":"11","author":"N Ngo","year":"2018","unstructured":"Ngo N, Susa M, Nakagawa T, Kawahara Y, Sato C, Horiuchi K, Kumazawa F, Shimazaki H, Anazawa U, Chiba K (2018) Malignant Transformation of Nodular Hidradenoma in the Lower Leg. Case Rep Oncol 11:298\u2013304. https:\/\/doi.org\/10.1159\/000489255","journal-title":"Case Rep Oncol"},{"key":"3176_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/ijd.13989","volume":"57","author":"EH Padoveze","year":"2018","unstructured":"Padoveze EH, Ocampo-Garza J, Di Chiacchio NG, Cernea SS, Di Chiacchio N, Ocampo\u2010Garza SS (2018) Mohs micrographic surgery for basal cell carcinoma of the scrotum. Int J Dermatol 57:750\u2013752. https:\/\/doi.org\/10.1111\/ijd.13989","journal-title":"Int J Dermatol"},{"key":"3176_CR43","doi-asserted-by":"publisher","first-page":"251584141984408","DOI":"10.1177\/2515841419844087","volume":"11","author":"C Pagano Boza","year":"2019","unstructured":"Pagano Boza C, Gonzalez-Barlatay J, Ugradar S, Pol M, Premoli EJ (2019) Syringocystadenocarcinoma papilliferum with orbital invasion: a case report with literature review. Ther Adv Ophthalmol 11:2515841419844087. https:\/\/doi.org\/10.1177\/2515841419844087","journal-title":"Ther Adv Ophthalmol"},{"key":"3176_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10:89. https:\/\/doi.org\/10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"3176_CR45","doi-asserted-by":"publisher","first-page":"453874","DOI":"10.1155\/2014\/453874","volume":"2014","author":"B Paradiso","year":"2014","unstructured":"Paradiso B, Bianchini E, Cifelli P, Cavazzini L, Lanza G (2014) A new case of syringocystadenocarcinoma papilliferum: a rare pathology for a wide-ranging comprehension. Case Rep Med 2014:453874. https:\/\/doi.org\/10.1155\/2014\/453874","journal-title":"Case Rep Med"},{"key":"3176_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/DAD.0000000000000370","volume":"38","author":"V Parekh","year":"2016","unstructured":"Parekh V, Guerrero CE, Knapp CF, Elmets CA, McKay KM (2016) A histological snapshot of hypothetical Multistep Progression from Nevus Sebaceus to Invasive Syringocystadenocarcinoma Papilliferum. Am J Dermatopathol 38:56\u201362. https:\/\/doi.org\/10.1097\/DAD.0000000000000370","journal-title":"Am J Dermatopathol"},{"key":"3176_CR47","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3346\/jkms.2007.22.4.762","volume":"22","author":"SH Park","year":"2007","unstructured":"Park SH, Shin YM, Shin DH, Choi JS, Kim KH (2007) Syringocystadenocarcinoma papilliferum: a case report. J Korean Med Sci 22:762\u2013765. https:\/\/doi.org\/10.3346\/jkms.2007.22.4.762","journal-title":"J Korean Med Sci"},{"key":"3176_CR48","doi-asserted-by":"publisher","first-page":"19620","DOI":"10.5070\/D3199019620","volume":"19","author":"J Peterson","year":"2013","unstructured":"Peterson J, Tefft K, Blackmon J, Rajpara A, Fraga G (2013) Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis. Dermatol Online J 19:19620","journal-title":"Dermatol Online J"},{"key":"3176_CR49","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1684\/ejd.2012.1723","volume":"22","author":"MA Plant","year":"2012","unstructured":"Plant MA, Sade S, Hong C, Ghazarian DMD (2012) Syringocystadenocarcinoma papilliferum in situ of the penis. Eur J Dermatol EJD 22:405\u2013406. https:\/\/doi.org\/10.1684\/ejd.2012.1723","journal-title":"Eur J Dermatol EJD"},{"key":"3176_CR50","doi-asserted-by":"publisher","unstructured":"Rao PB, Ghosh S, Mohapatra M, Philip NP, Kumar PR, Manam S, Karra P, Jasti VK (2015) Chemoradiotherapy in a case of malignant syringocystadenocarcinoma papilliferum of Vulva with Locoregional failure. Case Rep Oncol Med 2015(638294). https:\/\/doi.org\/10.1155\/2015\/638294","DOI":"10.1155\/2015\/638294"},{"key":"3176_CR51","doi-asserted-by":"publisher","first-page":"22335","DOI":"10.5070\/D3204022335","volume":"20","author":"E Satter","year":"2014","unstructured":"Satter E, Grady D, Schlocker CT (2014) Syringocystadenocarcinoma papilliferum with locoregional metastases. Dermatol Online J 20:22335","journal-title":"Dermatol Online J"},{"key":"3176_CR52","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.eucr.2021.101934","volume":"40","author":"M Shahidi Dadras","year":"2022","unstructured":"Shahidi Dadras M, Baghani M, Rakhshan A, Ansari Djafari A, Abdollahimajd F (2022) Genital syringocystadenocarcinoma papilliferum: an unusual location and review of the literature. Urol Case Rep 40:101934. https:\/\/doi.org\/10.1016\/j.eucr.2021.101934","journal-title":"Urol Case Rep"},{"key":"3176_CR53","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/DAD.0000000000000046","volume":"36","author":"S-J Shan","year":"2014","unstructured":"Shan S-J, Chen S, Heller P, Guo Y (2014) Syringocystadenocarcinoma papilliferum with intraepidermal pagetoid spread on an unusual location. Am J Dermatopathol 36:1007\u20131010. https:\/\/doi.org\/10.1097\/DAD.0000000000000046","journal-title":"Am J Dermatopathol"},{"key":"3176_CR54","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jamadermatol.2017.0397","volume":"153","author":"S Singh","year":"2017","unstructured":"Singh S, Khullar G, Sharma T, Elhence P (2017) An unusual case of Syringocystadenocarcinoma Papilliferum in situ with Macular Amyloidosis. JAMA Dermatol 153:725\u2013727. https:\/\/doi.org\/10.1001\/jamadermatol.2017.0397","journal-title":"JAMA Dermatol"},{"key":"3176_CR55","doi-asserted-by":"crossref","unstructured":"Soni A, Bansal N, Kaushal V, Chauhan AK (2015) Current management approach to hidradenocarcinoma: a comprehensive review of the literature. http:\/\/ecancer.org\/en\/journal\/article\/517-current-management-approach-to-hidradenocarcinoma-a-comprehensive-review-of-the-literature. Accessed 27 Apr 2024","DOI":"10.3332\/ecancer.2015.517"},{"key":"3176_CR56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1524-4725.2009.01403.x","volume":"36","author":"N Sroa","year":"2010","unstructured":"Sroa N, Sroa N, Zirwas M (2010) Syringocystadenocarcinoma papilliferum. Dermatol Surg off Publ Am Soc Dermatol Surg Al 36:261\u2013263. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01403.x","journal-title":"Dermatol Surg off Publ Am Soc Dermatol Surg Al"},{"key":"3176_CR57","unstructured":"Syringocystadenoma papilliferum https:\/\/www.pathologyoutlines.com\/topic\/skintumornonmelanocyticpapillarysyringadenoma.html. Accessed 27 Apr 2024"},{"key":"3176_CR58","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/DSS.0000000000001167","volume":"43","author":"SN Tolkachjov","year":"2017","unstructured":"Tolkachjov SN (2017) Adnexal Carcinomas Treated with Mohs Micrographic surgery: a Comprehensive Review. Dermatol Surg off Publ Am Soc Dermatol Surg Al 43:1199\u20131207. https:\/\/doi.org\/10.1097\/DSS.0000000000001167","journal-title":"Dermatol Surg off Publ Am Soc Dermatol Surg Al"},{"key":"3176_CR59","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1007\/s12070-021-02434-x","volume":"74","author":"RR Verma","year":"2022","unstructured":"Verma RR, Verma R (2022) Syringocystadenocarcinoma Papilliferum of External Auditory Canal: First Case Report in English literature. Indian J Otolaryngol Head Neck Surg off Publ Assoc Otolaryngol India 74:3700\u20133705. https:\/\/doi.org\/10.1007\/s12070-021-02434-x","journal-title":"Indian J Otolaryngol Head Neck Surg off Publ Assoc Otolaryngol India"},{"key":"3176_CR60","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2559.2006.02421.x","volume":"48","author":"H Woestenborghs","year":"2006","unstructured":"Woestenborghs H, Van Eyken P, Dans A (2006) Syringocystadenocarcinoma papilliferum in situ with pagetoid spread: a case report. Histopathology 48:869\u2013870. https:\/\/doi.org\/10.1111\/j.1365-2559.2006.02421.x","journal-title":"Histopathology"},{"key":"3176_CR61","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000526143","volume":"239","author":"Q Ye","year":"2023","unstructured":"Ye Q, Wu Q, Jia M, Li F-Z, Fang S (2023) Secondary tumors arising from Nevus Sebaceus: a Multicenter Collaborative Study and Literature Review. Dermatol Basel Switz 239:140\u2013147. https:\/\/doi.org\/10.1159\/000526143","journal-title":"Dermatol Basel Switz"},{"key":"3176_CR62","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/DAD.0b013e318235dd34","volume":"34","author":"YH Zhang","year":"2012","unstructured":"Zhang YH, Wang W-L, Rapini RP, Torres-Cabala C, Prieto VG, Curry JL (2012) Syringocystadenocarcinoma papilliferum with transition to areas of squamous differentiation: a case report and review of the literature. Am J Dermatopathol 34:428\u2013433. https:\/\/doi.org\/10.1097\/DAD.0b013e318235dd34","journal-title":"Am J Dermatopathol"},{"key":"3176_CR63","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/cup.12934","volume":"44","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Kong Y-Y, Cai X, Shen X-X, Kong J-C (2017) Syringocystadenocarcinoma papilliferum: clinicopathologic analysis of 10 cases. J Cutan Pathol 44:538\u2013543. https:\/\/doi.org\/10.1111\/cup.12934","journal-title":"J Cutan Pathol"},{"key":"3176_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000524821","volume":"14","author":"C Zilberg","year":"2022","unstructured":"Zilberg C, Paver E, Damian D (2022) Rapid Development of Syringocystadenocarcinoma Papilliferum in an immunosuppressed liver transplant recipient. Case Rep Dermatol 14:127\u2013131. https:\/\/doi.org\/10.1159\/000524821","journal-title":"Case Rep Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03176-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03176-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03176-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:35:30Z","timestamp":1725914130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03176-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,21]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3176"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03176-w","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,21]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial relationships relevant to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}},{"value":"All authors declare that they have no commercial or other associations that might pose a conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"421"}}